AngioDynamics (ANGO) Tops Q2 EPS by 10c, Beats on Revenue; Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.00, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $79.4 million versus the consensus estimate of $76.3 million.

GUIDANCE:

AngioDynamics sees FY2026 EPS of ($0.33)-($0.23), versus the consensus of ($0.33). AngioDynamics sees FY2026 revenue of $312-314 million, versus the consensus of $310 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• Kennametal (KMT) call put ratio 61 calls 1 put with a focus on 4300 contracts of October 35 calls
• FAA To Delay Boeing 737 Max 10 While Studying New Issue -Bedford